Reflect Scientific

Reflect Scientific

Reflect Scientific, Inc. trades on OTC Markets under the ticker RSCF and produces specialized thermal management equipment for life sciences applications. The company's product suite includes Cryometrix and MiraCool ultra-low temperature freezers, dry shippers, and liquid nitrogen transport containers designed to maintain cryogenic conditions for pharmaceuticals, vaccines, and laboratory samples. Founded in the 1990s by current CEO, Dr. John D. Green, it operates through wholly owned subsidiaries including Cryometrix, LLC and MiraCool. The company addresses the cold-chain logistics segment favored by biotech and government entities such as the U.S. military and Centers for Disease Control and Prevention (CDC). Its equipment is used for storing and shipping temperature-sensitive biological materials including mRNA vaccines and cell therapies. The business competes against Thermo Fisher Scientific and Panasonic Healthcare but targets a niche of smaller, specialized production runs. Revenue figures are reported in annual SEC filings as a public company. Headquarters are in Orem, Utah, with no disclosed additional offices. The firm employs fewer than 50 people based on its 10-K filings for fiscal years 2023 and 2024. In October 2023, Reflect Scientific reported a net loss of $1.2M on revenue of $4.8M for the prior fiscal year (per SEC SEC filing, FY2023). The company maintains no institutional investor base beyond public float and has no philanthropic vehicle or family office structure. One structural differentiator is Reflect Scientific's holding-company model — the corporate entity acts as a parent to distinct operating subsidiaries with separate brand identities and patent portfolios. This allows it to maintain lean overhead while offering a cross-subsidiary distribution network that smaller competitors lack. However, its thin public float and low revenue relative to peers make it a micro-cap with limited institutional coverage.